Niagen Bioscience: Study links CD38 enzyme to NAD+ decline in aging placental tissue

Go back to Niagen Bioscience: Study links CD38 enzyme to NAD+ decline in aging placental tissue
(NASDAQ: NAGE) Delayed: 3.05 --0 (-0%)
Previous Close $3.05    52 Week High $ 
Open $3.05    52 Week Low $ 
Day High $3.05    P/E N/A 
Day Low $3.05    EPS $ 
Volume 106